Colin Goddard, Chief Executive Officer at OSI PHARMACEUTICALS INC (OSIP), sold 41,000 shares at $37.36 ($1.5M) on 2007-06-04, disclosed to the SEC on 2007-06-06.
Scheduled sale ($1.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.75 | 10,744 | $395K | 26.0% |
| 2 | $36.84 | 5,000 | $184K | 12.1% |
| 3 | $36.99 | 10,000 | $370K | 24.4% |
| 4 | $37.04 | 1,200 | $44K | 2.9% |
| 5 | $37.07 | 1,500 | $56K | 3.7% |
| 6 | $37.15 | 3,050 |
| $113K |
| 7.5% |
| 7 | $37.16 | 100 | $4K | 0.2% |
| 8 | $37.17 | 2,550 | $95K | 6.3% |
| 9 | $37.18 | 100 | $4K | 0.2% |
| 10 | $37.19 | 100 | $4K | 0.2% |
| 11 | $37.20 | 100 | $4K | 0.2% |
| 12 | $37.21 | 300 | $11K | 0.7% |
| 13 | $37.22 | 400 | $15K | 1.0% |
| 14 | $37.23 | 4,100 | $153K | 10.1% |
| 15 | $37.24 | 200 | $7K | 0.5% |
| 16 | $37.25 | 400 | $15K | 1.0% |
| 17 | $37.26 | 500 | $19K | 1.2% |
| 18 | $37.27 | 100 | $4K | 0.2% |
| 19 | $37.35 | 482 | $18K | 1.2% |
| 20 | $37.36 | 74 | $3K | 0.2% |
| Total | $36.98 avg | 41,000 | $1.5M | 100% |
| Filing → |
| OSIP | SELL | 2010-03-03 | $3.6M | — | Filing → |
| OSIP | SELL | 2006-08-29 | $982K | — | Filing → |
| OSIP | SELL | 2006-08-29 | $100K | — | Filing → |